87 related articles for article (PubMed ID: 2878632)
1. Effects of beta adrenergic receptor agonists and antagonists in diabetics with symptoms of postural hypotension: a double-blind, placebo-controlled study.
Cleophas TJ; Kauw FH; Bijl C; Meijers J; Stapper G
Angiology; 1986 Nov; 37(11):855-62. PubMed ID: 2878632
[TBL] [Abstract][Full Text] [Related]
2. A double-blind crossover study of oral xamoterol in postural hypotension due to diabetic autonomic neuropathy.
Leslie PJ; Thompson C; Clarke BF; Ewing DJ
Clin Auton Res; 1991 Jun; 1(2):119-23. PubMed ID: 1688039
[TBL] [Abstract][Full Text] [Related]
3. No effect of Pindolol on postural hypotension in type 1 (insulin-dependent) diabetic patients with autonomic neuropathy. A randomised double-blind controlled study.
Dejgård A; Hilsted J
Diabetologia; 1988 May; 31(5):281-4. PubMed ID: 3294067
[TBL] [Abstract][Full Text] [Related]
4. Effects of beta-adrenoceptor agonists and antagonists in patients with peripheral autonomic neuropathy.
Man in't Veld AJ; Boomsma F; Schalekamp MA
Br J Clin Pharmacol; 1982; 13(Suppl 2):367S-374S. PubMed ID: 6125189
[No Abstract] [Full Text] [Related]
5. Alpha sympathomimetic treatment of autonomic insufficiency with orthostatic hypotension.
Fouad-Tarazi FM; Okabe M; Goren H
Am J Med; 1995 Dec; 99(6):604-10. PubMed ID: 7503082
[TBL] [Abstract][Full Text] [Related]
6. Effects of yohimbine, an alpha 2-adrenoceptor antagonist, on experimental neurogenic orthostatic hypotension.
Verwaerde P; Tran MA; Montastruc JL; Senard JM; Portolan G
Fundam Clin Pharmacol; 1997; 11(6):567-75. PubMed ID: 9444525
[TBL] [Abstract][Full Text] [Related]
7. Selectivity of beta-adrenoceptor agonists and antagonists in asthmatics.
Löfdahl CG
Eur J Respir Dis Suppl; 1982; 120():1-53. PubMed ID: 6125404
[No Abstract] [Full Text] [Related]
8. Xamoterol, a new selective beta-1-adrenoceptor partial agonist, in the treatment of postural hypotension.
Mehlsen J; Trap-Jensen J
Acta Med Scand; 1986; 219(2):173-7. PubMed ID: 2870611
[TBL] [Abstract][Full Text] [Related]
9. Alpha and beta-blockade and beta-stimulation in Raynaud's syndrome: a double-blind, placebo controlled, single dose study.
Cleophas TJ; Fennis JF; van 't Laar A
Angiology; 1985 Apr; 36(4):219-25. PubMed ID: 2862814
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.
Sramek JJ; Leibowitz MT; Weinstein SP; Rowe ED; Mendel CM; Levy B; McMahon FG; Mullican WS; Toth PD; Cutler NR
J Hum Hypertens; 2002 Jan; 16(1):13-9. PubMed ID: 11840225
[TBL] [Abstract][Full Text] [Related]
11. Haemodynamics of carvedilol in normal subjects compared with propranolol, pindolol, and labetalol.
Tomlinson B; Cronin CJ; Graham BR; Prichard BN
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S69-75. PubMed ID: 2454372
[TBL] [Abstract][Full Text] [Related]
12. Influence of beta-blockade with beta-1-selectivity or intrinsic sympathomimetic activity on some cardiorespiratory responses to exercise.
Yonga GO; Oyuga HW; Njeru EK
East Afr Med J; 1993 Jul; 70(7):405-8. PubMed ID: 7904931
[TBL] [Abstract][Full Text] [Related]
13. Hypotension with dobutamine: beta-adrenergic antagonist selectivity at low doses of carvedilol.
Lindenfeld J; Lowes BD; Bristow MR
Ann Pharmacother; 1999 Dec; 33(12):1266-9. PubMed ID: 10630826
[TBL] [Abstract][Full Text] [Related]
14. Ro 31-1118, a new cardioselective beta-adrenoceptor antagonist. Pharmacokinetics and effects on heart rate and blood pressure in mild hypertensives.
Jamieson M; Petrie JC; Webster J; Miller A; Harris RI; Francis RJ
Eur J Clin Pharmacol; 1985; 29(4):395-9. PubMed ID: 2868899
[TBL] [Abstract][Full Text] [Related]
15. A randomized trial of Korodin Herz-Kreislauf-Tropfen as add-on treatment in older patients with orthostatic hypotension.
Kroll M; Ring C; Gaus W; Hempel B
Phytomedicine; 2005 Jun; 12(6-7):395-402. PubMed ID: 16008114
[TBL] [Abstract][Full Text] [Related]
16. Effects on heart rate variability of metoprolol supplementary to ongoing ACE-inhibitor treatment in Type I diabetic patients with abnormal albuminuria.
Ebbehøj E; Poulsen PL; Hansen KW; Knudsen ST; Mølgaard H; Mogensen CE
Diabetologia; 2002 Jul; 45(7):965-75. PubMed ID: 12136395
[TBL] [Abstract][Full Text] [Related]
17. Intrinsic sympathomimetic activity counteracts beta-blocker inhibition of renin activation.
Ruddy MC; Bialy GB; Kostis JB
Angiology; 1989 Jan; 40(1):45-50. PubMed ID: 2562912
[TBL] [Abstract][Full Text] [Related]
18. [Fludrocortisone in the treatment of orthostatic hypotension: ophthalmodynamography during standing(author's transl)].
Finke J; Sagemüller I
Dtsch Med Wochenschr; 1975 Sep; 100(36):1790-2. PubMed ID: 1098888
[TBL] [Abstract][Full Text] [Related]
19. Decrease in beta-receptor density explaining the development of pindolol- and prenalterol-tolerance in orthostatic hypotension.
Andersen EB; Lindskov HO; Marving J; Boesen F; Beck-Nielsen H; Hesse B
Dan Med Bull; 1985 Jun; 32(3):194-6. PubMed ID: 2861975
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of beta-adrenoceptor partial agonists in patients with postural hypotension.
Mehlsen J; Stadeager C; Trap-Jensen J
Eur J Clin Pharmacol; 1993; 44(1):7-11. PubMed ID: 8436159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
